ZBTB44

gene
On this page

Also known as HSPC063ZNF851

Summary

ZBTB44 (zinc finger and BTB domain containing 44, HGNC:25001) is a protein-coding gene on chromosome 11q24.3, encoding Zinc finger and BTB domain-containing protein 44 (Q8NCP5). May be involved in transcriptional regulation.

Predicted to enable DNA binding activity and zinc ion binding activity. Predicted to be located in nucleus.

Source: NCBI Gene 29068 — RefSeq curated summary.

At a glance

  • GWAS associations: 6
  • Clinical variants (ClinVar): 59 total — 1 pathogenic
  • Druggable target: yes
  • MANE Select transcript: NM_001301098

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:25001
Approved symbolZBTB44
Namezinc finger and BTB domain containing 44
Location11q24.3
Locus typegene with protein product
StatusApproved
AliasesHSPC063, ZNF851
Ensembl geneENSG00000196323
Ensembl biotypeprotein_coding
Entrez29068

Gene structure

Transcript identifiers

Ensembl transcripts: 14 — 11 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay

ENST00000357899, ENST00000397753, ENST00000445008, ENST00000525623, ENST00000525842, ENST00000527478, ENST00000528448, ENST00000529348, ENST00000529982, ENST00000530205, ENST00000884638, ENST00000962913, ENST00000962914, ENST00000962915

RefSeq mRNA: 8 — MANE Select: NM_001301098 NM_001301098, NM_001301099, NM_001370219, NM_001370220, NM_001370221, NM_001370222, NM_001370223, NM_014155

CCDS: CCDS44776, CCDS73414, CCDS73415, CCDS91625

Canonical transcript exons

ENST00000357899 — 8 exons

ExonStartEnd
ENSE00001126571130239812130239896
ENSE00001195601130236793130237093
ENSE00001277720130238444130238607
ENSE00001382564130260856130261929
ENSE00002155538130314375130314917
ENSE00002156880130226677130231715
ENSE00003633271130234156130234273
ENSE00003646415130233308130233382

Expression profiles

Bgee: expression breadth ubiquitous, 268 present calls, max score 98.76.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 20.7291 / max 248.3128, expressed in 1791 samples.

FANTOM5 promoters (8 alternative TSS)

Promoter IDTPM avgSamples expressed
12317014.97661770
1231652.1385954
1231691.0981625
1231680.9292543
1231640.8007460
1231670.3820202
1231710.3051133
1231660.098936

Top tissues by expression

287 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
spermCL:000001998.76gold quality
renal medullaUBERON:000036298.35gold quality
biceps brachiiUBERON:000150798.10gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451197.91gold quality
caput epididymisUBERON:000435897.87gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450297.86gold quality
mammary ductUBERON:000176597.56gold quality
corpus epididymisUBERON:000435997.20gold quality
nippleUBERON:000203097.19gold quality
germinal epithelium of ovaryUBERON:000130497.15gold quality
cerebellar vermisUBERON:000472097.10gold quality
parietal pleuraUBERON:000240096.88gold quality
mucosa of paranasal sinusUBERON:000503096.58gold quality
visceral pleuraUBERON:000240196.45gold quality
trabecular bone tissueUBERON:000248396.45gold quality
seminal vesicleUBERON:000099896.20gold quality
pigmented layer of retinaUBERON:000178296.16gold quality
bronchial epithelial cellCL:000232896.08gold quality
superior surface of tongueUBERON:000737196.07gold quality
upper leg skinUBERON:000426296.04gold quality
penisUBERON:000098995.88gold quality
urethraUBERON:000005795.63gold quality
lateral globus pallidusUBERON:000247695.50gold quality
gingival epitheliumUBERON:000194995.47gold quality
jejunumUBERON:000211595.45gold quality
body of tongueUBERON:001187695.39gold quality
globus pallidusUBERON:000187595.34gold quality
medial globus pallidusUBERON:000247795.21gold quality
postcentral gyrusUBERON:000258195.20gold quality
tibiaUBERON:000097995.19gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes9.15

Regulation

Is transcription factor: yes

Downstream targets (CollecTRI)

1 targets.

TargetRegulation
CDKN2A

miRNA regulators (miRDB)

375 targeting ZBTB44, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3163100.0077.238605
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-30B-5P100.0076.293248
HSA-MIR-30C-5P100.0076.293248
HSA-MIR-30A-5P100.0076.313233
HSA-MIR-30D-5P100.0076.323233
HSA-MIR-30E-5P100.0076.323242
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-3064-3P100.0070.091254
HSA-MIR-1252-5P100.0069.802774
HSA-MIR-9-5P100.0072.282361
HSA-MIR-4668-3P100.0068.742635
HSA-MIR-3925-3P100.0069.951237
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-4262100.0073.263931
HSA-MIR-3646100.0073.565283
HSA-MIR-340-5P100.0072.504437
HSA-MIR-366299.9973.825684
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-428299.9975.366408
HSA-MIR-318599.9968.121959
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-186-5P99.9970.833707
HSA-MIR-196A-1-3P99.9972.152772
HSA-MIR-607799.9968.042299

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriozbtb44ENSDARG00000061110
mus_musculusZbtb44ENSMUSG00000047412
rattus_norvegicusZbtb44ENSRNOG00000005578
drosophila_melanogasterOpbpFBGN0050443

Paralogs (2): ZNF618 (ENSG00000157657), FIZ1 (ENSG00000179943)

Protein

Protein identifiers

Zinc finger and BTB domain-containing protein 44Q8NCP5 (reviewed: Q8NCP5)

Alternative names: BTB/POZ domain-containing protein 15, Zinc finger protein 851

All UniProt accessions (5): A0A0A0MTE9, Q8NCP5, H0YCZ0, H0YEM9, H7BY22

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Isoforms (4)

UniProt IDNamesCanonical?
Q8NCP5-11yes
Q8NCP5-22
Q8NCP5-33
Q8NCP5-44

RefSeq proteins (8): NP_001288027, NP_001288028, NP_001357148, NP_001357149, NP_001357150, NP_001357151, NP_001357152, NP_054874 (=MANE)

Domains & families (InterPro)

IDNameType
IPR000210BTB/POZ_domDomain
IPR011333SKP1/BTB/POZ_sfHomologous_superfamily
IPR013087Znf_C2H2_typeDomain
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096, PF00651

UniProt features (27 total): modified residue 7, zinc finger region 4, splice variant 4, compositionally biased region 3, region of interest 3, cross-link 2, chain 1, domain 1, sequence variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8NCP5-F155.170.08

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (9): 135, 159, 161, 165, 191, 194, 200, 4, 290

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 224 (showing top): GCACCTT_MIR18A_MIR18B, TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497, AAGCCAT_MIR135A_MIR135B, TACAATC_MIR508, CACCAGC_MIR138, TATCTGG_MIR488, TTGGAGA_MIR5155P_MIR519E, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, ZHANG_BREAST_CANCER_PROGENITORS_UP, CUI_TCF21_TARGETS_2_DN, CTGAGCC_MIR24, chr11q24, GABRIELY_MIR21_TARGETS, BRCA1_DN.V1_DN, IL15_UP.V1_DN

GO Biological Process (0):

GO Molecular Function (4): DNA binding (GO:0003677), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
nucleic acid binding1
transition metal ion binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

722 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZBTB44MRPS14O60783539
ZBTB44ZSWIM8A7E2V4528
ZBTB44NBEAL1Q6ZS30472
ZBTB44TAF9BQ9HBM6456
ZBTB44BMS1Q14692454
ZBTB44DDX52Q9Y2R4453
ZBTB44SMURF2Q9HAU4442
ZBTB44SLC39A13Q96H72427
ZBTB44SERTAD4Q9NUC0424
ZBTB44ZER1Q7Z7L7420
ZBTB44CLEC17AQ6ZS10417
ZBTB44SLC15A2Q16348416
ZBTB44SACSQ9NZJ4400
ZBTB44ECM1Q16610393
ZBTB44RHOBTB3O94955386

IntAct

44 interactions, top by confidence:

ABTypeScore
SMYD1ZBTB44psi-mi:“MI:0915”(physical association)0.740
ZBTB44SMYD1psi-mi:“MI:0915”(physical association)0.740
ZBTB44GLRX3psi-mi:“MI:0915”(physical association)0.560
RAD23AZBTB44psi-mi:“MI:0915”(physical association)0.560
ZBTB44PSMA6psi-mi:“MI:0915”(physical association)0.560
ZBTB44FAM124Apsi-mi:“MI:0915”(physical association)0.560
WDFY3ZBTB44psi-mi:“MI:0915”(physical association)0.560
ZBTB44AP1M1psi-mi:“MI:0915”(physical association)0.560
POLIZBTB44psi-mi:“MI:0915”(physical association)0.560
ZBTB44RAD23Apsi-mi:“MI:0915”(physical association)0.560
PSMA6ZBTB44psi-mi:“MI:0915”(physical association)0.560
ZBTB44WDFY3psi-mi:“MI:0915”(physical association)0.560
ZBTB44POLIpsi-mi:“MI:0915”(physical association)0.560
PSG9CCDC85Cpsi-mi:“MI:0914”(association)0.530
CAMK1GRFWD3psi-mi:“MI:0914”(association)0.530
ZBTB44ZBTB44psi-mi:“MI:0915”(physical association)0.370
APBA3ZBTB44psi-mi:“MI:0915”(physical association)0.370

BioGRID (84): ZBTB44 (Two-hybrid), ZBTB44 (Two-hybrid), ZBTB44 (Two-hybrid), ZBTB44 (Two-hybrid), ZBTB44 (Two-hybrid), ZBTB44 (Two-hybrid), ZBTB44 (Two-hybrid), SMYD1 (Two-hybrid), FAM124A (Two-hybrid), ZBTB44 (Affinity Capture-MS), ZBTB44 (Affinity Capture-MS), UBA3 (Affinity Capture-MS), MYH14 (Affinity Capture-MS), USP7 (Affinity Capture-MS), SCRIB (Affinity Capture-MS)

ESM2 similar proteins: A0A1D5NS60, A0JN76, A1YFX5, A2T7G6, A6NJL1, D2HQI1, F1MJR8, O14901, P0CG00, P10754, P22227, P98182, Q0IJ29, Q1L8W0, Q3SWU4, Q5DW34, Q5EAC5, Q5EXX3, Q5RHB5, Q5SXI5, Q5T619, Q66H04, Q6NRM8, Q6NV66, Q6ZSB9, Q7M6U3, Q7TS63, Q7TSH3, Q7ZWZ4, Q801P1, Q86VK4, Q8BKX7, Q8BXX2, Q8NAM6, Q8NAP3, Q8NCP5, Q8R0A2, Q91VW9, Q96IT1, Q96N77

Diamond homologs: A0A2R8Q1W5, A9JRD8, B0WWP2, B3DIV9, B3M9V8, B3NDN0, B4GRJ2, B4HIK1, B4J045, B4L0G9, B4LIG6, B4MXW3, B4PD06, B4QLQ2, D3Z8N4, D3ZUU2, E0CZ16, E1B932, E7F6F9, E9Q4F2, F1LZ52, F1LZF0, F1MBP6, G3X9X1, O15062, O93567, O94889, O95198, P28575, P57790, Q04652, Q08DK3, Q13105, Q14145, Q16RL8, Q1ECZ2, Q2M0J9, Q2TBA0, Q3SWU4, Q3ZB90

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

59 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance45
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
815477GRCh37/hg19 11q24.2-25(chr11:124232608-134938470)x1Pathogenic

SpliceAI

1740 predictions. Top by Δscore:

VariantEffectΔscore
11:130233306:A:ACdonor_gain1.0000
11:130233307:C:CCdonor_gain1.0000
11:130233997:A:ACdonor_gain1.0000
11:130233998:A:Cdonor_gain1.0000
11:130236763:T:TAdonor_gain1.0000
11:130236787:CCTCA:Cdonor_loss1.0000
11:130236788:CTCAC:Cdonor_loss1.0000
11:130236789:TCA:Tdonor_loss1.0000
11:130236790:CAC:Cdonor_loss1.0000
11:130236791:A:Cdonor_loss1.0000
11:130236792:CCTG:Cdonor_gain1.0000
11:130237089:AATTC:Aacceptor_gain1.0000
11:130237090:ATTC:Aacceptor_gain1.0000
11:130237091:TTC:Tacceptor_gain1.0000
11:130237092:TC:Tacceptor_gain1.0000
11:130237093:CC:Cacceptor_gain1.0000
11:130237094:C:CCacceptor_gain1.0000
11:130237094:C:CGacceptor_loss1.0000
11:130237095:T:Cacceptor_loss1.0000
11:130238442:A:AGdonor_loss1.0000
11:130238443:CCTG:Cdonor_loss1.0000
11:130239806:A:ACdonor_gain1.0000
11:130239807:C:CCdonor_gain1.0000
11:130239808:TGA:Tdonor_loss1.0000
11:130239809:GA:Gdonor_loss1.0000
11:130239810:A:ACdonor_gain1.0000
11:130239810:ACCGA:Adonor_loss1.0000
11:130239811:C:CCdonor_gain1.0000
11:130239811:C:CGdonor_loss1.0000
11:130239897:C:CCacceptor_gain1.0000

AlphaMissense

3767 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
11:130236873:G:CF496L1.000
11:130236873:G:TF496L1.000
11:130236874:A:GF496S1.000
11:130236875:A:GF496L1.000
11:130237053:G:CF436L1.000
11:130237053:G:TF436L1.000
11:130237054:A:GF436S1.000
11:130237055:A:GF436L1.000
11:130238470:A:GL414P1.000
11:130238487:G:CF408L1.000
11:130238487:G:TF408L1.000
11:130238488:A:GF408S1.000
11:130238489:A:GF408L1.000
11:130238508:A:CC401W1.000
11:130238509:C:GC401S1.000
11:130238510:A:GC401R1.000
11:130238510:A:TC401S1.000
11:130236874:A:CF496C0.999
11:130236969:G:CF464L0.999
11:130236969:G:TF464L0.999
11:130236971:A:GF464L0.999
11:130236992:A:GC457R0.999
11:130237028:G:CH445D0.999
11:130237036:A:GL442P0.999
11:130237047:C:AR438S0.999
11:130237047:C:GR438S0.999
11:130237048:C:AR438M0.999
11:130237067:A:GC432R0.999
11:130237076:A:GC429R0.999
11:130237080:A:CF427L0.999

dbSNP variants (sampled 300 via entrez): RS1000011780 (11:130303041 T>C,G), RS1000015652 (11:130266536 A>G), RS1000027205 (11:130282642 C>G,T), RS1000083558 (11:130248752 A>G), RS1000148684 (11:130299188 A>G), RS1000167481 (11:130307333 G>A), RS1000201183 (11:130287964 A>AC), RS1000216185 (11:130244951 G>C), RS1000221690 (11:130267265 A>G,T), RS1000265004 (11:130307138 C>T), RS1000321559 (11:130312989 G>T), RS1000330440 (11:130276944 G>A), RS1000433028 (11:130313521 T>C), RS1000475430 (11:130238498 C>T), RS1000504613 (11:130306207 A>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

6 associations (top):

StudyTraitp-value
GCST007094_139Diastolic blood pressure1.000000e-12
GCST007096_197Pulse pressure8.000000e-69
GCST007097_21Pulse pressure3.000000e-21
GCST007097_22Pulse pressure3.000000e-17
GCST007097_23Pulse pressure2.000000e-06
GCST007099_69Systolic blood pressure6.000000e-15

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0006336diastolic blood pressure
EFO:0005763pulse pressure measurement
EFO:0006335systolic blood pressure

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL5069367 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

43 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects cotreatment, decreases expression, affects expression6
sodium arseniteaffects methylation, affects cotreatment, decreases expression, increases abundance, increases expression3
Arsenicaffects methylation, affects cotreatment, decreases expression, increases abundance, increases expression3
Phenylmercuric Acetateaffects cotreatment, increases expression2
Cadmium Chlorideincreases abundance, increases expression2
aristolochic acid Idecreases expression1
FR900359increases phosphorylation1
TAK-243increases sumoylation1
methylmercuric chloridedecreases expression1
triphenyl phosphateaffects expression1
bisphenol Aincreases methylation1
butyraldehydedecreases expression1
manganese chlorideaffects cotreatment, decreases expression, increases abundance1
benzo(e)pyrenedecreases methylation1
pinosylvindecreases expression1
avobenzoneincreases expression1
di-n-butylphosphoric acidaffects expression1
CGP 52608affects binding, increases reaction1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, increases expression, decreases expression1
dorsomorphinaffects cotreatment, increases expression, decreases expression1
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidineincreases expression, increases response to substance1
jinfukangdecreases expression1
Temozolomideincreases expression1
Sunitinibincreases expression1
Acetaminophendecreases expression1
Benzo(a)pyreneaffects methylation1
Cadmiumincreases abundance, increases expression1
Caffeineincreases phosphorylation1
Demecolcinedecreases expression1
Drugs, Chinese Herbalincreases expression1

ChEMBL screening assays

3 unique, capped per target: 3 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL5059500BindingProteomics fold change data (SUDHL4 cells, 1h)Data for DCP probe CCT369260

Cellosaurus cell lines

3 cell lines: 3 embryonic stem cell

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_A8A5SEES3-1V human ZBTB44, clone1Embryonic stem cellMale
CVCL_A8A6SEES3-1V human ZBTB44, clone2Embryonic stem cellMale
CVCL_A8A7SEES3-1V human ZBTB44, clone3Embryonic stem cellMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.